BRIANI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.773
AS - Asia 15.406
EU - Europa 7.643
AF - Africa 3.023
SA - Sud America 2.903
Continente sconosciuto - Info sul continente non disponibili 913
OC - Oceania 299
Totale 61.960
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.034
SG - Singapore 4.478
CN - Cina 2.448
VN - Vietnam 2.047
HK - Hong Kong 1.811
BR - Brasile 1.699
IT - Italia 1.501
FR - Francia 688
BD - Bangladesh 609
DE - Germania 601
FI - Finlandia 600
IN - India 443
SE - Svezia 401
GB - Regno Unito 355
UA - Ucraina 318
RU - Federazione Russa 303
IQ - Iraq 301
PL - Polonia 292
AR - Argentina 268
TR - Turchia 254
NL - Olanda 251
PK - Pakistan 200
CA - Canada 199
PH - Filippine 194
JP - Giappone 183
MX - Messico 179
SA - Arabia Saudita 171
ID - Indonesia 166
ZA - Sudafrica 154
EC - Ecuador 150
VE - Venezuela 137
CO - Colombia 133
ES - Italia 133
AT - Austria 129
UZ - Uzbekistan 119
RO - Romania 115
JM - Giamaica 114
IE - Irlanda 104
PY - Paraguay 104
MY - Malesia 103
CI - Costa d'Avorio 102
JO - Giordania 102
PE - Perù 102
AE - Emirati Arabi Uniti 101
PT - Portogallo 101
EG - Egitto 100
KZ - Kazakistan 99
MA - Marocco 98
NP - Nepal 95
CH - Svizzera 94
DZ - Algeria 94
BJ - Benin 93
DO - Repubblica Dominicana 93
HR - Croazia 93
IL - Israele 92
RS - Serbia 92
NI - Nicaragua 91
SN - Senegal 91
TN - Tunisia 91
CL - Cile 90
KR - Corea 90
PS - Palestinian Territory 90
SI - Slovenia 90
AL - Albania 89
CR - Costa Rica 89
KG - Kirghizistan 89
TH - Thailandia 88
AO - Angola 87
CZ - Repubblica Ceca 86
LY - Libia 86
ET - Etiopia 85
GT - Guatemala 85
KE - Kenya 85
HN - Honduras 84
UY - Uruguay 84
AZ - Azerbaigian 82
MD - Moldavia 82
TT - Trinidad e Tobago 81
ZM - Zambia 81
LA - Repubblica Popolare Democratica del Laos 80
LV - Lettonia 80
BY - Bielorussia 79
KH - Cambogia 79
GA - Gabon 78
GN - Guinea 78
LU - Lussemburgo 78
LC - Santa Lucia 77
XK - ???statistics.table.value.countryCode.XK??? 77
PA - Panama 76
EE - Estonia 75
MK - Macedonia 75
SO - Somalia 75
HU - Ungheria 74
LB - Libano 74
BO - Bolivia 73
GH - Ghana 73
TJ - Tagikistan 73
IR - Iran 72
MG - Madagascar 72
BB - Barbados 71
Totale 57.625
Salva come PNG Salva come JPEG
Città #
Fairfield 3.679
Ashburn 3.172
Woodbridge 2.726
Singapore 2.611
San Jose 2.561
Houston 1.992
Hong Kong 1.640
Ann Arbor 1.605
Seattle 1.407
Cambridge 1.349
Wilmington 1.228
Chandler 1.005
Jacksonville 869
Ho Chi Minh City 610
Santa Clara 565
Boardman 485
Hanoi 482
Princeton 458
Los Angeles 454
Beijing 426
San Diego 397
New York 307
Lauterbourg 306
Helsinki 247
Medford 224
Chicago 189
São Paulo 170
Des Moines 158
Bytom 156
Nanjing 156
Roxbury 153
Padova 152
The Dalles 151
Council Bluffs 146
Guangzhou 135
Munich 129
Milan 128
Baghdad 118
Rome 114
Da Nang 106
Tashkent 100
Dong Ket 99
Abidjan 98
Tokyo 98
Buffalo 96
Orem 94
Amman 91
Managua 90
Dakar 89
Cotonou 88
Vienna 87
Dublin 84
Dallas 82
London 82
Bishkek 79
Baku 78
Conakry 77
Lusaka 77
Istanbul 76
Warsaw 76
Castries 74
Kingston 74
Haiphong 73
Libreville 70
Panama City 70
San José 68
Dushanbe 67
Montevideo 67
Phnom Penh 67
Vientiane 67
Antananarivo 65
Bridgetown 65
Johannesburg 65
Riga 65
Addis Ababa 64
Kigali 64
Luanda 64
Rio de Janeiro 64
Shenyang 64
Stockholm 64
Ulan Bator 64
Nairobi 63
Nouakchott 63
Podgorica 63
Accra 62
Andorra la Vella 62
Harare 61
Havana 60
Turku 60
Bamako 59
Guayaquil 59
Jeddah 59
Kuala Lumpur 59
Lahore 59
Noumea 59
Willemstad 59
Amsterdam 58
Nuremberg 58
Atlanta 57
Frankfurt am Main 57
Totale 37.249
Salva come PNG Salva come JPEG
Nome #
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 395
Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management 327
Brain anatomical substrates of mirror movements in Kallmann syndrome 318
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 309
Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies 307
Long-term plasma exchange in pediatric CIDP. 305
Evaluation of peripherin in biofluids of patients with motor neuron diseases 290
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 287
Anti-ganglioside autoantibodies in type 1 diabetes. 281
γ-Hydroxybutyric acid-induced psychosis and seizures. 281
'Snake eyes' MRI sign: possible role of cobalt toxicity? 277
Brain changes in Kallmann syndrome 275
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 265
Acute amnestic syndrome in isolated bilateral fornix stroke. 264
Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. 262
Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact. 259
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients 259
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. 257
Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy 253
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia 253
Peptide Receptor Radionuclide Therapy in a Case of Multiple Spinal Canal and Cranial Paragangliomas 252
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 252
Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings. 251
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. 251
Magnetic Resonance Imaging Correlates of Immune Microenvironment in Glioblastoma 251
Clinical implications of autoantibody screening in patients with autoimmune myositis. 250
Immunomodulatory drugs in plasma cell diseases: everything has its price 249
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 248
The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients 246
Lenalidomide long-term neurotoxicity: clinical and neurophysiological prospective study. 245
The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy. 244
Heterogeneity of root and nerve ultrasound pattern in CIDP patients 243
Assessment of Neuropathic Pain in Erosive Hand Osteoarthritis 242
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance 242
Free light chains and heavy/light chains in monitoring POEMS patients. 241
Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology? 239
Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study. 239
Adult onset Charcot-Marie-Tooth disease type 1D with an Arg381Cys mutation of EGR2. 238
Possible neuroleukemiosis in two patients with acute myeloid leukemia in complete bone marrow remission 238
Anti-ganglioside antibodies in children with coeliac disease: correlation with gluten-free diet and neurological complications. 237
Intraparenchymal ventricular diverticula in chronic obstructive hydrocephalus: prevalence, imaging features and evolution 236
Exploring neuropathic symptoms in a large cohort of Italian patients with different peripheral nervous system diseases. 233
RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE 233
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia 231
Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosis 231
Correspondence between Neurophysiological and Clinical Measurements of Chemotherapy-Induced Peripheral Neuropathy: Secondary Analysis of Data from the CIPeriNoms Study. 230
Degeneration and Plasticity of the Optic Pathway in Alström Syndrome. 228
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post-hoc analysis of a prospective study 228
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 228
Isaacs’ syndrome with overlapping myopathy as the first manifestation of AL amyloidosis 227
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 226
Angiographic diagnosis of primary central nervous system vasculitis with spinal cord involvement 225
Neurological complications of celiac disease and autoimmune mechanisms: a prospective study 224
Novel mutation of the mitofusin 2 gene in a family with Charcot-Marie-Tooth disease type 2 (CMT2A). 224
Brain Changes in Kallmann Syndrome 222
Intra- and internerve cross-sectional area variability: New ultrasound measures. 222
Whipple's disease without gastrointestinal symptoms: a challenging diagnosis. 220
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 220
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 219
A Prospective Cohort Study On Patients Treated With Anticoagulants For Cerebral Vein Thrombosis. 218
Ischemic stroke as clinical onset of POEMS syndrome. 218
Leukocytoclastic vasculitis associated with multifocal sensory neuropathy responsive to intravenous immunoglobulins: a case report 217
Radiological evidence of subclinical dysphagia in motor neuron disease 216
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 216
IgM MGUS and Waldenstromassociated anti-MAG neuropathies display similar response to rituximab therapy 214
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 214
Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-MAG antibody polyneuropathy 214
Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment. 213
Reversible isolated sensory axonal neuropathy due to cobalamin deficiency. 213
Unexpected nerve neuroimaging findings in Friedreich's ataxia. 212
Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma 212
Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients. 212
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. 211
Cobalamin deficiency: clinical picture and radiological findings. 211
Nerve ultrasound in CANVAS‐spectrum disease: Reduced nerve size distinguishes genetically confirmed CANVAS from other axonal polyneuropathies 210
Combined analysis of CSF ßA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's Disease: preliminary data 210
Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. 209
Nerve Ultrasound findings in neuropathy associated with anti-MAG antibodies 209
Disulfiram-induced peripheral and central neurotoxicity 208
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients. 208
Absence of angiogenic genes modification in Italian ALS patients. 207
Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy 207
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: potential relevance of antibody titers in monitoring treatment response 206
Multifocal neurological involvement as the only manifestation of IgG4-related disease. 206
No major progranulin genetic variability contribution to diseaseetiopathogenesis in an ALS Italian cohort. 205
RFC1 expansions are a common cause of idiopathic sensory neuropathy 204
Peripheral nerve involvement in wild-type transthyretin amyloidosis 203
TAPENTADOL EXTENDED RELEASE FOR CHRONIC MODERATE-TO-SEVERE LOW BACK PAIN IN THE ELDERLY 203
Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. 201
Rituximab-responsive CIDP 200
A case of Ciguatera poisoning with paradoxical dysaesthesia and degenerative features at skin biopsy 200
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 199
Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. 198
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 198
SPECT imaging of the brain in dementia: follow-up evaluation 198
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy. 197
Chronic inflammatory demyelinating polyradiculoneuropathy: Can we make a diagnosis in patients not fulfilling electrodiagnostic criteria? 197
Long-term effect of rituximab in anti-mag polyneuropathy 196
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. 196
Nerve Ultrasound and 3D-MR Neurography suggestive of intraneural Perineurioma. 196
Totale 23.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 170.370
article - articoli 160.549
book - libri 983
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.302
Totale 337.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.464 0 564 730 259 153 316 245 569 253 124 460 791
2022/20232.449 590 144 60 232 446 275 11 170 328 17 127 49
2023/20241.420 50 147 140 100 94 225 96 40 66 56 181 225
2024/20256.743 36 395 318 204 903 150 358 569 629 344 1.128 1.709
2025/202629.617 1.101 2.473 4.513 5.245 2.357 1.152 3.563 2.511 2.929 1.742 1.162 869
2026/20271.416 1.256 160 0 0 0 0 0 0 0 0 0 0
Totale 61.960